"Patient Nr. ","Sex ","Age ","Disease duration [years] ","Pretreatment ","EDSS ","Stable disease course "
1,F,23,3,Interferon-beta,1.5,Yes
2,F,54,9,None,2,Yes
3,M,28,4,Interferon-beta,1.5,Yes
4,M,33,14,Natalizumab,4,Yes
5,F,42,14,Glatiramer acetate,3,Yes
6,F,53,16,Interferon-beta,3.5,Yes
7,F,47,3,Interferon-beta,3,Yes
8,F,47,7,Interferon-beta,2,Yes
9,F,41,11,Interferon-beta,6,Yes
10,F,46,15,Natalizumab,4,Yes
11,F,42,2,None,1,Yes
12,F,19,2,None,1.5,Yes
13,F,30,11,Natalizumab,2,Yes
14,M,35,3,Glatiramer acetate,2,Yes
15,M,27,3,Glatiramer acetate,2,Yes
16,F,44,4,Interferon-beta,2.5,Yes
17,F,27,11,Natalizumab,2,No
18,F,29,15,Natalizumab,6,Yes
19,F,24,11,None,1,Yes
20,F,47,6,Glatiramer acetate,3,Yes
21,F,45,11,Glatiramer acetate,1.5,Yes
22,M,42,3,Glatiramer acetate,4,Yes
23,F,44,10,Interferon-beta,1.5,Yes
24,M,38,3,Glatiramer acetate,1.5,Yes
25,M,26,4,Interferon-beta,1.5,No
26,F,42,4,Glatiramer acetate,2,Yes
27,M,29,2,Glatiramer acetate,2,Yes
28,F,35,2,Glatiramer acetate,3,Yes
29,M,41,1,None,2,Yes
30,M,30,6,Interferon-beta,1.5,Yes
31,M,28,1,None,1.5,Yes
32,M,44,10,Interferon-beta,4,Yes
33,F,45,10,Interferon-beta,4,Yes
34,M,41,19,Natalizumab,3,Yes
35,F,33,8,Glatiramer acetate,2.5,Yes
